Furosemide and Coarctation Surgery Lung Complications

Furosemide: Would it Help to Improve the Lungs During Aortic Coarctation Surgery

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03364842

Enrollment

Registered

2017-12-07

Start date

2017-11-22

Completion date

2017-12-20

Last updated

2017-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Complication

Brief summary

in our study the investigators give furosemide during surgery for repair of aortic coarctation via lateral thoracotomy and evaluated lung complications in comparison to control group

Interventions

DRUGFurosemide

Administering furosemide

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

1 Months to 18 Months

Healthy volunteers

Inclusion criteria

* coarctation of aorta

Exclusion criteria

* heart failure, bleeding diathesis, associated cardiac congenital anomalies

Design outcomes

Primary

Measure	Time frame
lung ultrasonography scale > 24	a 1 year study

Secondary

Measure	Time frame
Pao2/ Fio2 ratio	a 1 year study

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026